CrossrefInfokarte
Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”
Intestinal Research · 2026-10-31 · 24 (4) · 813-814
DOI: 10.5217/ir.2026.00062 ↗Abstract
Kein Abstract verfügbar.
EUVIMED